Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy

被引:23
作者
Chen, Luyao [1 ]
Ma, Xin [1 ]
Li, Hongzhao [1 ]
Gu, Liangyou [1 ]
Li, Xintao [1 ]
Gao, Yu [1 ]
Xie, Yongpeng [1 ,2 ]
Zhang, Xu [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China
[2] Nankai Univ, Sch Med, Tianjin, Peoples R China
关键词
PERINEPHRIC FAT INFILTRATION; TNM STAGING SYSTEM; PROGNOSTIC-SIGNIFICANCE; MULTICENTER EXPERIENCE; T3A; CLASSIFICATION; CANCER; IMPACT;
D O I
10.1371/journal.pone.0173953
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Objective To evaluate the prognostic significance of tumor size in pathological T3aN0M0 renal cell carcinoma (RCC) treated by radical nephrectomy. Materials and methods Patients who underwent radical nephrectomy for sporadic RCC with pathological T3aN0M0 RCC at our institution between January 2006 and June 2015 were identified. The entire cohort was divided into two groups according to the cutoff of tumor size obtained from receiver operating characteristic (ROC) curve. Clinicopathological variables were retrospectively collected and compared. Kaplan-Meier analysis and multivariate Cox regression were conducted to evaluate the effect of tumor size on survival outcomes. Results 163 pT3aNOMO RCC patients were included with a median follow-up period of 31 months. The optimal cutoff for tumor size was 7 cm according to the ROC curve. 90 cases (55.2%) presented tumors which measured 7 cm or less, and 73 cases (44.8%) showed tumor size greater than 7 cm. Patients with larger tumors tended to exhibit higher rates of symptoms and higher Fuhrman grades; they also indicated more necrosis features, and were more likely to invade the collecting system and renal vein. Compared with patients who exhibited tumor size of <= 7 cm, those with tumor size>7 cm were associated with shorter estimated five-year cancer-specific survival (CSS, 46.6% versus 75.0%, P=0.003) and five-year recurrence-free survival (RFS, 35.6% versus 62.7%, P = 0.011). Multivariate Cox analysis revealed that tumor size was retained as an independent factor for CSS (HR = 2.506, 95% CI 1.169-5.373, P=0.018). Conclusions The tumor size significantly affected the survival outcomes of pT3aN0M0 RCC treated by radical nephrectomy, and a cutoff size of 7 cm can help enhance the prognostic discrimination. Thus, the tumor size may be considered in the future TNM classification of stage pT3a.
引用
收藏
页数:10
相关论文
共 21 条
[1]
Evaluation of the Prognostic Significance of Perirenal Fat Invasion and Tumor Size in Patients with pT1-pT3a Localized Renal Cell Carcinoma in a Comprehensive Multicenter Study of the CORONA project. Can We Improve Prognostic Discrimination for Patients with Stage pT3a tumors? [J].
Brookman-May, Sabine D. ;
May, Matthias ;
Wolff, Ingmar ;
Zigeuner, Richard ;
Hutterer, Georg C. ;
Cindolo, Luca ;
Schips, Luigi ;
De Cobelli, Ottavio ;
Rocco, Bernardo ;
De Nunzio, Cosimo ;
Tubaro, Andrea ;
Coman, Ioman ;
Truss, Michael ;
Dalpiaz, Orietta ;
Feciche, Bogdan ;
Figenshau, Robert S. ;
Madison, Kerry ;
Sanchez-Chapado, Manuel ;
Santiago Martin, Maria del Carmen ;
Salzano, Luigi ;
Lotrecchiano, Giuseppe ;
Zastrow, Stefan ;
Wirth, Manfred ;
Sountoulides, Petros ;
Shariat, Shahrokh ;
Waidelich, Raphaela ;
Stief, Christian ;
Gunia, Sven .
EUROPEAN UROLOGY, 2015, 67 (05) :943-951
[2]
Pathological Stage T3a Significantly Increases Disease Recurrence across All Tumor Sizes in Renal Cell Carcinoma [J].
Chevinsky, Michael ;
Imnadze, Mariam ;
Sankin, Alexander ;
Winer, Andrew ;
Mano, Roy ;
Jakubowski, Christopher ;
Mashni, Joseph ;
Sjoberg, Daniel D. ;
Chen, Ying-Bei ;
Tickoo, Satish K. ;
Reuter, Victor E. ;
Hakimi, A. Ari ;
Russo, Paul .
JOURNAL OF UROLOGY, 2015, 194 (02) :310-315
[3]
Lymph Node Dissection at the Time of Radical Nephrectomy for High-Risk Clear Cell Renal Cell Carcinoma: Indications and Recommendations for Surgical Templates [J].
Crispen, Paul L. ;
Breau, Rodney H. ;
Allmer, Cristine ;
Lohse, Christine M. ;
Cheville, John C. ;
Leibovich, Bradley C. ;
Blute, Michael L. .
EUROPEAN UROLOGY, 2011, 59 (01) :18-23
[4]
Cancer Treatment and Survivorship Statistics, 2014 [J].
DeSantis, Carol E. ;
Lin, Chun Chieh ;
Mariotto, Angela B. ;
Siegel, Rebecca L. ;
Stein, Kevin D. ;
Kramer, Joan L. ;
Alteri, Rick ;
Robbins, Anthony S. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (04) :252-271
[5]
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[6]
Reassessment of the 1997 TNM classification system for renal cell carcinoma - A 5-cm T1/T2 cutoff is a better predictor of clinical outcome [J].
Elmore, JM ;
Kadesky, KT ;
Koeneman, KS ;
Sagalowsky, AI .
CANCER, 2003, 98 (11) :2329-2334
[7]
TNM staging system for renal-cell carcinoma: current status and future perspectives [J].
Ficarra, Vincenzo ;
Galfano, Antonio ;
Mancini, Mariangela ;
Martignoni, Guido ;
Artibani, Walter .
LANCET ONCOLOGY, 2007, 8 (06) :554-558
[8]
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score [J].
Frank, I ;
Blute, ML ;
Cheville, JC ;
Lohse, CM ;
Weaver, AL ;
Zincke, H .
JOURNAL OF UROLOGY, 2002, 168 (06) :2395-2400
[9]
PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[10]
Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? [J].
Gofrit, Ofer N. ;
Shapiro, Amos ;
Pizov, Galina ;
Landau, Ezekiel H. ;
Katz, Ran ;
Zorn, Kevin C. ;
Pode, Dov .
JOURNAL OF UROLOGY, 2007, 177 (05) :1682-1686